Fentanyl From the Government? A Vancouver Experiment Aims to Stop Overdoses
A city on the forefront of harm reduction has taken the concept to a new level in an effort to address the growing toxicity of […]
A city on the forefront of harm reduction has taken the concept to a new level in an effort to address the growing toxicity of […]
The deal would end thousands of lawsuits against one of the largest producers of opioid painkillers during the height of the opioid epidemic.
The deal would end thousands of lawsuits against one of the largest producers of opioid painkillers during the height of the opioid epidemic.
A city on the forefront of harm reduction has taken the concept to a new level in an effort to address the growing toxicity of […]
A city on the forefront of harm reduction has taken the concept to a new level in an effort to address the growing toxicity of […]
The deal would end thousands of lawsuits against one of the largest producers of opioid painkillers during the height of the opioid epidemic.
Why haven’t we solved the addiction crisis?
The consulting firm offered clients “in-depth experience in narcotics,” from poppy fields to pills more powerful than Purdue’s OxyContin.
Why haven’t we solved the addiction crisis?
In a unanimous ruling, the justices ordered federal appeals courts to reconsider the cases of two doctors convicted of violating the Controlled Substances Act.
In a unanimous ruling, the justices ordered federal appeals courts to reconsider the cases of two doctors convicted of violating the Controlled Substances Act.
In a unanimous ruling, the justices ordered federal appeals courts to reconsider the cases of two doctors convicted of violating the Controlled Substances Act.
In a unanimous ruling, the justices ordered federal appeals courts to reconsider the cases of two doctors convicted of violating the Controlled Substances Act.
Why haven’t we solved the addiction crisis?
Why haven’t we solved the addiction crisis?
The soaring drug fatalities in the U.S. are being fueled partly by fentanyl-tainted pills bought by teenagers and young adults on Snapchat, Instagram, TikTok and […]
Three critical questions to secure F.D.A. integrity.
The consulting firm’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.
The consulting firm’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.
The consulting firm’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.
The consulting firm’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.
Three critical questions to secure F.D.A. integrity.
Three critical questions to secure F.D.A. integrity.
We answer a common reader question about the opioid crisis and legalizing drugs.
We answer a common reader question about the opioid crisis and legalizing drugs.
The firm let consultants advise both drugmakers and their government overseers, internal records show. “Who we know and what we know” was part of their […]
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The narrow 50-46 decision underscored the divisions on both sides of the aisle over agency policies on opioids and abortion medications and his ties to […]
The agency threw out previous recommended limits on doses but encouraged “nonopioid therapies” wherever possible.
Dr. Robert Califf, a former agency commissioner, is encountering opposition over federal opioid and abortion policies and his industry ties.
Dr. Robert Califf, a former agency commissioner, is encountering opposition over federal opioid and abortion policies and his industry ties.
Money from the tentative deal would go toward addiction and treatment and would be overseen by Native American tribal leaders.
In “The Hard Sell,” the journalist Evan Hughes tells the story of the rise and fall of Insys Therapeutics — and the larger pharmaceutical industry.
The case was the first of its kind, targeting every point of the prescription opioid supply chain, from manufacturers to pharmacy chains that filled prescriptions.
The case was the first of its kind, targeting every point of the prescription opioid supply chain, from manufacturers to pharmacy chains that filled prescriptions.
The case was the first of its kind, targeting every point of the prescription opioid supply chain, from manufacturers to pharmacy chains that filled prescriptions.
The case was the first of its kind, targeting every point of the prescription opioid supply chain, from manufacturers to pharmacy chains that filled prescriptions.
The case was the first of its kind, targeting every point of the prescription opioid supply chain, from manufacturers to pharmacy chains that filled prescriptions.
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
A Senate panel hearing on Tuesday signaled that Dr. Robert Califf, who briefly led the agency during the Obama administration, had some bipartisan support.
A Senate panel hearing on Tuesday signaled that Dr. Robert Califf, who briefly led the agency during the Obama administration, had some bipartisan support.
A Senate panel hearing on Tuesday signaled that Dr. Robert Califf, who briefly led the agency during the Obama administration, had some bipartisan support.
A Senate panel hearing on Tuesday signaled that Dr. Robert Califf, who briefly led the agency during the Obama administration, had some bipartisan support.
This is the first jury verdict in an opioid case. The decision embraced a key legal argument that judges in other opioid cases had recently […]
This is the first jury verdict in an opioid case. The decision embraced a key legal argument that judges in other opioid cases had recently […]
This is the first jury verdict in an opioid case. The decision embraced a key legal argument that judges in other opioid cases had recently […]
This is the first jury verdict in an opioid case. The decision embraced a key legal argument that judges in other opioid cases had recently […]
This is the first jury verdict in an opioid case. The decision embraced a key legal argument that judges in other opioid cases had recently […]
This is the first jury verdict in an opioids case. The decision embraced a key legal argument that judges in other opioids cases had recently […]
The 135-year-old company announced plans to divide itself into a consumer products business and a medical company.
The 135-year-old company announced plans to divide itself into a consumer products business and a medical company.
The 135-year-old company announced plans to divide itself into a consumer products business and a medical company.
The 135-year-old company announced plans to divide itself into a consumer products business and a medical company.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
In one of the first cases to be brought against drug manufacturers over the crisis, a judge ruled that there was “simply no evidence” the […]
In one of the first cases to be brought against drug manufacturers over the crisis, a judge ruled that there was “simply no evidence” the […]
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
In one of the first cases to be brought against drug manufacturers over the crisis, a judge ruled that there was “simply no evidence” the […]
In one of the first cases to be brought against drug manufacturers over the crisis, a judge ruled that there was “simply no evidence” the […]
Should we decriminalize drugs, or legalize?
It depends.
Too often, seniors who use opioids become targets for exploitation and abuse.
Too often, seniors who use opioids become targets for exploitation and abuse.
Too often, seniors who use opioids become targets for exploitation and abuse.
Too often, seniors who use opioids become targets for exploitation and abuse.
Too often, seniors who use opioids become targets for exploitation and abuse.
The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family […]
The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family […]
The deaths over three days in Suffolk County reflect a dangerous shift in the street-drug marketplace, according to police and prosecutors.
In a rare courtroom appearance, the former Purdue Pharma president and board member was evasive and defiant.
In a rare courtroom appearance, the former Purdue Pharma president and board member was evasive and defiant.
In a rare court appearance, David Sackler said he and his family would withdraw their pledge to pay $4.5 billion, unless they are shielded from […]
In a rare court appearance, David Sackler said he and his family would withdraw their pledge to pay $4.5 billion, unless they are granted broad […]
If approved by a judge next month, the plan would resolve thousands of lawsuits and set in motion the release of $4.5 billion to help […]
If approved by a judge next month, the plan would resolve thousands of lawsuits and set in motion the release of $4.5 billion to help […]
The agreement would allow funds to begin flowing from the companies to states and communities to pay for addiction and prevention services.
The payout to New York will take place over the next 17 years, and joins a $26 billion deal to settle the thousands of nationwide […]
The agreement would allow funds to begin flowing from the companies to states and communities to pay for addiction and prevention services.
The agreement would end thousands of lawsuits against the three largest distributors and Johnson & Johnson and require them to pay billions for addiction treatment […]
Three drug distributors and Johnson & Johnson are also on the verge of a $26 billion deal to settle the thousands of nationwide lawsuits.
The agreement would end thousands of lawsuits against the three largest distributors and Johnson & Johnson and require them to pay billions for addiction treatment […]
The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.
The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.
New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.
New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.
New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.
The settlement agreement came just days before opening arguments in a sweeping trial of several defendants, including the company.
The settlement agreement came just days before opening arguments in a sweeping trial of several defendants, including the company.
The settlement agreement came just days before opening arguments in a sweeping trial of several defendants, including the company.
Mr. Hanly had been central to the current nationwide litigation against pharmaceutical companies, pharmacies and others in the opioid supply chain.
Mr. Hanly had been central to the current nationwide litigation against pharmaceutical companies, pharmacies and others in the opioid supply chain.
Mr. Hanly had been central to the current nationwide litigation against pharmaceutical companies, pharmacies and others in the opioid supply chain.
The consulting firm has reached the agreement with 47 states because of its advice to drugmakers, including Purdue Pharma, the manufacturer of OxyContin.
The 160-page civil complaint alleges the retailer knew its system for detecting illegitimate prescriptions was inadequate.
The 160-page civil complaint alleges the retailer knew its system for detecting illegitimate prescriptions was inadequate.
The 160-page civil complaint alleges the retailer knew its system for detecting illegitimate prescriptions was inadequate.
The 160-page civil complaint alleges that the retail giant knew that its system for detecting illegitimate prescriptions was inadequate.
The firm faced criticism after a report revealed that consultants had discussed destroying documents related to the opioid business and proposed that a drugmaker pay […]
The firm faced criticism after a report revealed that consultants had discussed destroying documents related to the opioid business and proposed that a drugmaker pay […]
Parents should not be afraid of managing the child’s pain with opioids when they are needed, but should make sure a child does not have […]
Court filings reveal consultants’ talk of a records purge during the opioid crisis, and shed new light on sales advice given to the billionaire Sackler […]
Copyright © 2024 | WordPress Theme by MH Themes